Established in 2003, the company is a high-tech listed enterprise (SZ.300267) with core advantages in the entire pharmaceutical manufacturing industry chain, and is an important promoter and setter of standards for the pharmaceutical excipients industry in China. With the mission of “everything for drug safety”, the company has developed into a multinational enterprise group integrating pharmaceutical intermediates, APIs, pharmaceutical excipients, pharmaceutical preparations, traditional Chinese medicine and health industries, relying on two high-standard national research platforms, the “National Pharmaceutical Excipients Engineering Technology Research Center” and the “National Enterprise Technology Center”, guided by technological innovation and driven by the upgrading of drug quality and safety standards. The company's main business includes the production and sale of excipients, APIs, and finished pharmaceuticals. The main products are medicinal ethanol, medicinal glycerin, modified starch and starch capsule series products, citric acid series products, sucrose and compound excipients, sulfadiol, sodium sulfadiene injections, aminocaproic acid injections, aminophylline injections, calamine injections, calamine injections, calamine tablets, manna ghee pills, etc. Corporate honors: National Certified Enterprise Technology Center, Vice Chairman Unit of the National Pharmaceutical Chamber of Commerce, 2015 Jinniu Listed Companies Top 100, Top 10 GEM Listed Companies in the 10th China Listed Company Value Selection, Top 10 GEM Listed Companies by Value, Excellent Unit for Innovative Corporate Culture Construction, etc.